Osimertinib, third-generation irreversible EGFR-TKI, treats EGFR-mutated NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, anti-CNS metastasis, targeted therapy,
Sale!
Lucius
Replica Osimertinib EGFR Ex19Del/L858R Targeted Lung Cancer Med
Original price was: $688.00.$529.00Current price is: $529.00.
Osimertinib, third-generation irreversible EGFR-TKI, treats EGFR-mutated NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, anti-CNS metastasis, targeted therapy,